- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 13, 2024 | 26.66M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 27.49M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 25.55M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$76.21K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$74.42K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $47.22K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $72.91K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $2.16M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $1.55M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$1.37M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$1.04M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $1.34M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $1.92M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $1.96M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $2.56M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $4.12M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $4.11M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $4.13M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $4.12M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.02 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.02 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $404.54K |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $48.53K |
| Net Income | Q1 2024 · Mar 31, 2024 | $610.17K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$332.22K |
| Operating Income | Q1 2024 · Mar 31, 2024 | $783.41K |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$48.53K |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $1.19M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $649.49K |
| Revenue | Q1 2024 · Mar 31, 2024 | $1.84M |
| Stock Issued | Q1 2024 · Mar 13, 2023 | 162.39K sh |